Related Experiment Video
Updated: Mar 15, 2026

A Doxorubicin-Induced Murine Model of Dilated Cardiomyopathy In Vivo
Published on: May 16, 2020
Alcoholic cardiomyopathy : The result of dosage and individual predisposition
1Herz- und Gefäßzentrum Marburg (HGZ) und Philipps Universität Marburg, Feldbergstr. 45, 35043, Marburg, Deutschland. bermaisch@gmail.com.
Insights
Moderate alcohol consumption benefits cardiovascular health, while excessive intake can cause alcoholic cardiomyopathy. This condition involves heart muscle damage from ethanol toxicity, requiring abstinence and heart failure treatment.
Area of Science:
- Cardiology
- Toxicology
- Public Health
Background:
- Alcohol consumption's health effects vary based on quantity, with moderate intake potentially benefiting cardiovascular health.
- Excessive alcohol intake can lead to alcoholic cardiomyopathy, a direct toxic effect of ethanol on heart muscle.
- Other alcohol-related heart conditions include beriberi heart disease, cardiac cirrhosis, and toxic cardiomyopathies from contaminants.
Purpose of the Study:
- To define alcoholic cardiomyopathy and differentiate it from other alcohol-related cardiac issues.
- To outline the diagnostic criteria for alcoholic cardiomyopathy.
- To describe the recommended treatment for alcoholic cardiomyopathy.
Main Methods:
- Review of existing data on alcohol consumption and cardiovascular outcomes.
- Analysis of etiological factors in various alcohol-induced heart diseases.
- Description of diagnostic markers including carbohydrate deficient transferrin (CDT), liver enzymes, and cardiac biomarkers (NT-proBNP, troponins, CKMb).
Main Results:
- Moderate drinking (1-2 drinks/men, 1 drink/women) is associated with reduced risk of coronary artery disease, heart failure, diabetes, and stroke.
- Alcoholic cardiomyopathy results from direct ethanol toxicity, distinct from other alcohol-related heart conditions.
- Diagnosis requires confirmation of alcohol abuse and cardiac involvement via specific biomarkers.
Conclusions:
- Alcoholic cardiomyopathy is a serious condition caused by chronic heavy alcohol use.
- Early diagnosis and intervention, including alcohol abstinence and heart failure management, are crucial.
- Understanding the dose-dependent effects of alcohol is key for cardiovascular health and disease prevention.
Abstract:
The individual amount of alcohol consumed acutely or chronically decides on harm or benefit to a person's health. Available data suggest that one to two drinks in men and one drink in women will benefit the cardiovascular system over time, one drink being 17.6 ml 100 % alcohol. Moderate drinking can reduce the incidence and mortality of coronary artery disease, heart failure, diabetes, ischemic and hemorrhagic stroke. More than this amount can lead to alcoholic cardiomyopathy, which is defined as alcohol toxicity to the heart muscle itself by ethanol and its metabolites. Historical examples of interest are the Munich beer heart and the Tübingen wine heart. Associated with chronic alcohol abuse but having different etiologies are beriberi heart disease (vitamin B1 deficiency) and cardiac cirrhosis as hyperdynamic cardiomyopathies, arsenic poising in the Manchester beer epidemic, and cobalt intoxication in Quebec beer drinker's disease. Chronic heavy alcohol abuse will also increase blood pressure and cause a downregulation of the immune system that could lead to increased susceptibility to infections, which in turn could add to the development of heart failure. Myocardial tissue analysis resembles idiopathic cardiomyopathy or chronic myocarditis. In the diagnostic work-up of alcoholic cardiomyopathy, the confirmation of alcohol abuse by carbohydrate deficient transferrin (CDT) and increased liver enzymes, and the involvement of the heart by markers of heart failure (e.g., NT-proBNP) and of necrosis (e.g., troponins or CKMb) is mandatory. Treatment of alcoholic cardiomyopathy consists of alcohol abstinence and heart failure medication.
More Related Videos
09:16Isolation and Characterization of Cardiac Mesenchymal Stromal Cells from Endomyocardial Bioptic Samples of Arrhythmogenic Cardiomyopathy Patients
Published on: February 28, 2018
03:45Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
Published on: August 8, 2022
Related Concept Videos
Cardiomyopathy I: Introduction and Classification
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy V: Interprofessional Care
Cardiomyopathy IV: Restrictive Cardiomyopathy
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Myocarditis I: Introduction